![Carmine Valenza: The role of gBRCA-PV in post-PARPi myeloid neoplasms, in patients with ovarian cancer](https://oncodaily.com/pub/uploads/2024/09/detail-main-Ovarian-Cancer-e1682332023373-2.png)
photo taken from www.narayanahealth.org
Sep 2, 2024, 17:22
Carmine Valenza: The role of gBRCA-PV in post-PARPi myeloid neoplasms, in patients with ovarian cancer
Carmine Valenza, MPH Student at Harvard T.H. Chan School of Public Health, shared a post on X:
“Just out on ESMO Open our last contribution on the role of gBRCA-PV in post-PARPi myeloid neoplasms, in patients with ovarian cancer.
In heavily pretreated patients, gBRCA impact seems to be even higher than PARPi exposure .
Thanks to all the coauthors!
Authors: C.Valenza , M. Mongillo, F.Gigli, D.Trapani, J.Katrini, E.Nicolò, L.Boldrini, L.Boscolo Bielo, G.Castellano, L.Guidi, G.Pellizzari, S.Derio,M.Lapresa, G.Parma, E.Derenzini, G.Curigliano, N.Colombo.
Source: Carmine Valenza/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023